Juno Therapeutics, Inc. Uncategorized Contracts & Agreements
25 Contracts & Agreements
- Letter Agreement, dated October 6, 2017, by and among Celgene Corporation, Celgene Switzerland LLC and the registrant (Filed With SEC on March 1, 2018)
- Offer Letter Agreement, dated November 8, 2017, by and between Ann Lee and the registrant (Filed With SEC on March 1, 2018)
- Form of Tax Reimbursement Agreement (Filed With SEC on February 1, 2018)
- Offer Letter Agreement, dated April 13, 2017, by and between Sunil Agarwal, M.D. and the registrant (Filed With SEC on August 3, 2017)
- Amendment No. 3 to Sponsored Research Agreement, effective May 2, 2017, by and between Seattle Childrens Hospital d/b/a Seattle Childrens Research Institute and the registrant (Filed With SEC on August 3, 2017)
- Amendment No. 2 to Sponsored Research Agreement, effective March 31, 2017, by and between Seattle Childrens Hospital d/b/a Seattle Childrens Research Institute and the registrant (Filed With SEC on August 3, 2017)
- JUNO THERAPEUTICS, INC. INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 1, 2017)
- [Juno Letterhead] (Filed With SEC on August 5, 2016)
- JunoTherapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 (Filed With SEC on February 29, 2016)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 (Filed With SEC on February 29, 2016)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 May 27, 2015 (Filed With SEC on August 14, 2015)
- AMENDMENT NO. 2 to EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on August 14, 2015)
- NON-EXCLUSIVE SUBLICENSE AGREEMENT (Filed With SEC on August 14, 2015)
- AMENDMENT NO. 1 TO SPONSORED RESEARCH AGREEMENT (Filed With SEC on May 12, 2015)
- MASTER CLINICAL STUDY AGREEMENT (Filed With SEC on December 16, 2014)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 March 20, 2014 (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 January 13, 2014 (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 January 1, 2014 (Filed With SEC on November 17, 2014)
- FC Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631 September 5, 2013 (Filed With SEC on November 17, 2014)
- SPONSORED RESEARCH AGREEMENT (Filed With SEC on November 17, 2014)
- Amendment No. 1 to the ExclusiveLicense Agreement (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631 (Filed With SEC on November 17, 2014)
- MASTER CLINICAL STUDY AGREEMENT (Filed With SEC on November 17, 2014)
- MASTER SPONSORED RESEARCH AGREEMENT By and between MEMORIALSLOAN-KETTERING CANCER CENTER And Sponsor (Filed With SEC on November 17, 2014)
- FC Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631 (Filed With SEC on November 17, 2014)
